ADAPTIVE
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Aug 2022)
What this means for you
This application is over — abandoned 22 Aug 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87878584
- Mark type
- Design + words
- Filed
- 16 Apr 2018
- Published for opposition
- 13 Nov 2018
- Abandoned
- 22 Aug 2022
- Attorney of record
- Hoang-chi Truong
Goods and services
- Class 042 — Scientific and technological services: Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy
- Class 044 — Medical, beauty and agricultural services: Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly
Owner
- Adaptive Biotechnologies Corporation, Seattle, WA, US
- Adaptive Biotechnologies Corporation, Seattle, WA, US
Prosecution history
- 22 Aug 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Aug 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Jul 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Jul 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Jul 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Jan 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Dec 2021 — TTAB RELEASE CASE TO TRADEMARKS
- 07 Dec 2021 — OPPOSITION DISMISSED NO. 999999
- 10 Dec 2020 — CASE ASSIGNED TO TTAB
- 10 Dec 2020 — NOTICE OF ALLOWANCE CANCELLED
- 18 Aug 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jul 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Jul 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Jul 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Jul 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED